Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C

Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 2

Abstract

Authors and Affiliations

Mohammed Eslam, Reyes Aparcero, M. Romero-Gomez

Keywords

Related Articles

Serum lipids and chronic hepatitis C genotype 4: interaction and significance

Background & aim. Metabolic abnormalities are common in chronic hepatitis C infection (CHC). However, the genotypic differences of these disarrangements in patients infected with CHC genotype 4 (HCV-4) and it...

Hepatitis B viral load and risk of HBV-related liver disease: from East to West?

Chronic hepatitis B has a variable course in disease activity with a risk of clinical complications like liver cirrhosis and hepatocellular carcinoma. As clinical symptoms present in a late stage of the disease, identifi...

Mexican-native human echinococcosis: Case report of an underestimated disease

Mexico is considered a virtually free region of cystic echinococcosis. Almost all case reports within the country involve immigrants or traveling patients. This manuscript presents a Mexican-native human echinococcosis t...

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis

Introduction. Primary sclerosing cholangitis (PSC) is an idiopathic hepatobiliary disorder associated with an increased risk for cholangiocarcinoma (CCA) and a median survival time of 12 years. Reliable predictors of CCA...

Protective role of standardized Feronia limonia stem bark methanolic extract against carbon tetrachloride induced hepatotoxicity

Objective. This study evaluates hepatoprotective potential of Feronia limonia stem bark (FSB) extracts and fractions using experimental models. Materials and methods. Activity levels of aspartate aminotransferase (AST) a...

Download PDF file
  • EP ID EP78035
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

Mohammed Eslam, Reyes Aparcero, M. Romero-Gomez (2011). Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Annals of Hepatology, 10(2), 241-243. https://europub.co.uk./articles/-A-78035